The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment

Marilyn J. Hockenberry, Olga A. Taylor, Alice Pasvogel, Cheryl Rodgers, Kathy McCarthy, Patricia Gundy, David W. Montgomery, Phillip Ribbeck, Michael E. Scheurer, Ida M. Moore

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Purpose/Objectives: To explore the symptom trajectory during the first 16 months of childhood leukemia treatment and any associations with the oxidative stress pathway measured by cerebrospinal fluid (CSF) concentration of oxidized phosphatidylcholine (PC), the predominant glycerophospholipid in the brain and cell membranes. Design: Prospective, longitudinal design. Setting: Two cancer centers in the southwestern United States. Sample: 36 children (aged 3-14 years) newly diagnosed with acute lymphoblastic leukemia. Methods: Symptoms were measured using the Memorial Symptom Assessment Scale at six specific time points during treatment. Biochemical changes in oxidative stress were measured by oxidized PC in the CSF. Main Research Variables: Childhood cancer symptoms, oxidized PC. Findings: Significant differences were found in the number of symptoms experienced during the three phases of treatment. Symptom trajectory changes and influence of the oxidative stress pathway on symptom experiences were identified. Conclusions: Symptoms experienced during treatment for childhood leukemia are associated with increased oxidative stress. Implications for Nursing: Children with leukemia experience symptoms throughout treatment. Physiologic measures indicate the influence of oxidative stress on symptoms.

Original languageEnglish (US)
Pages (from-to)E238-E247
JournalOncology nursing forum
Issue number4
StatePublished - Jul 2014


  • Fatigue
  • Leukemia/lymphomas/hematology
  • Symptoms

ASJC Scopus subject areas

  • Oncology(nursing)


Dive into the research topics of 'The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment'. Together they form a unique fingerprint.

Cite this